[custom-mapping height=”624″ width=”960″ map_id=”2351″]
Clinical Trial Map
Recent Posts
- Cerebrovascular, cardiovascular disease risk seen higher in SSc
- FDA grants orphan drug status to BLR-200 for scleroderma
- 2 blood proteins may help detect lung issues in scleroderma patients
- Resilience may curb negative effects of feeling socially isolated: Study
- CABA-201 gets FDA orphan drug status as scleroderma treatment
- How scleroderma has changed my face, despite my best efforts
- T-helper cells may affect lung disease severity in SSc: StudyÂ
- Joint inflammation, health-related quality of life linked in SSc: Study
- Cognitive difficulties, malnutrition can be common with scleroderma
- Frequency of muscle disease in SSc shows need for biomarkers: Study